Your cart is empty
Your cart is currently empty. Let us assist you in finding the right product.
ALUTS is an alpha-1 blocker taken once a day. It relaxes smooth muscle in the prostate and bladder neck to improve urinary flow, and the house positions it for better ejaculatory function than other alpha blockers, including in cardiovascular, elderly, and hypertensive patients.
MRP ₹180
ALUTS is alfuzosin hydrochloride prolonged-release tablets IP 10 mg. It is an alpha-1 blocker taken once a day. The page says it relaxes smooth muscle in the prostate and bladder neck to improve urinary flow. The house positions it for better ejaculatory function than other alpha blockers, including in cardiovascular, elderly, and hypertensive patients. That positioning is the house’s comparison. This site does not add a table against silodosin or tamsulosin, and it does not name a percentage the house did not print. The indications are moderate to severe LUTS associated with benign prostatic hyperplasia in adult, sexually active men; weak stream, hesitancy, difficulty starting, and incomplete emptying; and a higher chance of a successful trial without catheter after acute urinary retention.
Once daily is the whole dose line. There is no “after a meal” clause, unlike SILUTS-4 and SILUTS-8. There is no dutasteride in the tablet, unlike SILUTS-D8 and TALUTS-D. There is no probiotic, unlike UGAXIS-P. Alfuzosin is its own row. The pack is 10 × 10 tablets. The MRP is ₹180, which will look like a bargain next to SILUTS-D8 at ₹415 if someone is shopping by price. Shopping by price across alpha blockers is how the ejaculatory sentence and the renal sentence get lost. ₹180 buys alfuzosin 10 mg prolonged release. It does not buy a quieter version of silodosin.
The phrase “sexually active men” is on the indication, next to moderate to severe LUTS. It is there because the house put it there, in the same breath as the ejaculatory positioning. Do not detach it and turn it into a lifestyle campaign. Do not drop it and sell the tablet as a general flow product for every older man. Cardiovascular, elderly, and hypertensive patients are named in the house’s positioning. They are a reason to read the page carefully, not a guarantee printed as an outcome. The successful trial without catheter is likewise the house’s indication line. Quote it. Do not extend it to ureteral stones. That 76 percent figure lives on TALUTS 0.4 and must not be borrowed by a cheaper neighbour.
When the sidebar shows the rest of urology, use it to say what ALUTS is not. It is not the combination. It is not the 4 mg renal pack. It is not the overactive-bladder pair. An order can still include more than one brand if the physician has written more than one, but the lines have to be separate. Say ALUTS, 10 mg, 10 × 10, once daily, MRP ₹180. The pack photograph is the client’s. There is nothing to redesign about the strip except the honesty of the sentence wrapped around it.
Your cart is currently empty. Let us assist you in finding the right product.
Cookie preferences